End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
10,930
KRW
|
-0.18%
|
|
-1.09%
|
-8.07%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
697,868
|
952,407
|
965,199
|
596,925
|
783,143
|
725,827
|
-
|
Enterprise Value (EV)
2 |
791.9
|
1,039
|
1,071
|
710
|
783.1
|
832.3
|
764.4
|
P/E ratio
|
21.7
x
|
34.4
x
|
21.4
x
|
14.3
x
|
19.5
x
|
11.4
x
|
9.44
x
|
Yield
|
0.36%
|
0.52%
|
0.68%
|
1.1%
|
-
|
0.91%
|
0.91%
|
Capitalization / Revenue
|
1.33
x
|
1.7
x
|
1.54
x
|
0.78
x
|
0.91
x
|
0.69
x
|
0.64
x
|
EV / Revenue
|
1.51
x
|
1.85
x
|
1.71
x
|
0.93
x
|
0.91
x
|
0.79
x
|
0.67
x
|
EV / EBITDA
|
14
x
|
15.6
x
|
14.7
x
|
7.62
x
|
8.3
x
|
6.06
x
|
4.76
x
|
EV / FCF
|
-39.6
x
|
39.3
x
|
24.3
x
|
94.2
x
|
-
|
15.6
x
|
9.62
x
|
FCF Yield
|
-2.53%
|
2.55%
|
4.11%
|
1.06%
|
-
|
6.4%
|
10.4%
|
Price to Book
|
2.47
x
|
2.72
x
|
1.93
x
|
1.16
x
|
-
|
1.33
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
55,481
|
59,994
|
66,110
|
65,886
|
65,866
|
66,407
|
-
|
Reference price
3 |
12,579
|
15,875
|
14,600
|
9,060
|
11,890
|
10,930
|
10,930
|
Announcement Date
|
1/30/20
|
2/5/21
|
3/17/22
|
2/6/23
|
1/29/24
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
524.3
|
561.9
|
627.3
|
760.5
|
859.6
|
1,050
|
1,137
|
EBITDA
1 |
56.49
|
66.78
|
72.74
|
93.16
|
94.38
|
137.3
|
160.6
|
EBIT
1 |
39.05
|
39.99
|
41.45
|
56.6
|
68.27
|
99.25
|
118
|
Operating Margin
|
7.45%
|
7.12%
|
6.61%
|
7.44%
|
7.94%
|
9.45%
|
10.37%
|
Earnings before Tax (EBT)
1 |
42.46
|
36.04
|
70.72
|
58.92
|
56.31
|
91.8
|
111.9
|
Net income
1 |
32.22
|
26.86
|
43.04
|
40.92
|
40.2
|
66.05
|
79.57
|
Net margin
|
6.15%
|
4.78%
|
6.86%
|
5.38%
|
4.68%
|
6.29%
|
7%
|
EPS
2 |
580.4
|
460.8
|
683.0
|
634.0
|
610.0
|
962.0
|
1,158
|
Free Cash Flow
3 |
-20,021
|
26,470
|
44,034
|
7,538
|
-
|
53,300
|
79,500
|
FCF margin
|
-3,818.89%
|
4,711.1%
|
7,019.85%
|
991.2%
|
-
|
5,074.26%
|
6,991.26%
|
FCF Conversion (EBITDA)
|
-
|
39,637.57%
|
60,534.45%
|
8,091.42%
|
-
|
38,810.68%
|
49,512.14%
|
FCF Conversion (Net income)
|
-
|
98,562.38%
|
102,299.55%
|
18,422.29%
|
-
|
80,696.44%
|
99,916.21%
|
Dividend per Share
2 |
45.46
|
83.33
|
100.0
|
100.0
|
-
|
100.0
|
100.0
|
Announcement Date
|
1/30/20
|
2/5/21
|
3/17/22
|
2/6/23
|
1/29/24
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
167.4
|
165.6
|
178.6
|
182.5
|
197.9
|
201.5
|
203.8
|
216.3
|
208.3
|
231.2
|
249.5
|
261
|
269.8
|
270.2
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
18.97
|
5.218
|
16.99
|
-
|
16.62
|
9.182
|
16
|
19.04
|
18.46
|
14.78
|
21.8
|
27.1
|
28.65
|
21.7
|
Operating Margin
|
11.33%
|
3.15%
|
9.51%
|
-
|
8.4%
|
4.56%
|
7.85%
|
8.8%
|
8.86%
|
6.39%
|
8.74%
|
10.39%
|
10.62%
|
8.03%
|
Earnings before Tax (EBT)
|
36.13
|
6.876
|
16.44
|
-
|
-
|
-8.517
|
15.83
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
20.57
|
5.677
|
11.18
|
15.1
|
-
|
-6.339
|
11.35
|
-
|
11.94
|
5.738
|
15.35
|
18.95
|
20
|
11.8
|
Net margin
|
12.28%
|
3.43%
|
6.26%
|
8.27%
|
-
|
-3.15%
|
5.57%
|
-
|
5.73%
|
2.48%
|
6.15%
|
7.26%
|
7.41%
|
4.37%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/15/21
|
3/17/22
|
5/16/22
|
8/16/22
|
11/14/22
|
2/6/23
|
4/27/23
|
7/27/23
|
10/25/23
|
1/29/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
94
|
86.8
|
106
|
113
|
-
|
107
|
38.6
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.664
x
|
1.3
x
|
1.454
x
|
1.214
x
|
-
|
0.7755
x
|
0.2404
x
|
Free Cash Flow
2 |
-20,021
|
26,470
|
44,034
|
7,538
|
-
|
53,300
|
79,500
|
ROE (net income / shareholders' equity)
|
12%
|
8%
|
10.6%
|
8.27%
|
-
|
11.4%
|
12.4%
|
ROA (Net income/ Total Assets)
|
6.73%
|
4.3%
|
5.83%
|
4.87%
|
-
|
6.8%
|
7.6%
|
Assets
1 |
478.8
|
624.2
|
738.3
|
840.4
|
-
|
971.3
|
1,047
|
Book Value Per Share
3 |
5,100
|
5,845
|
7,582
|
7,831
|
-
|
8,200
|
9,361
|
Cash Flow per Share
|
847.0
|
769.0
|
955.0
|
421.0
|
-
|
-
|
-
|
Capex
1 |
67
|
18.3
|
16.1
|
20.3
|
-
|
22.7
|
25.4
|
Capex / Sales
|
12.78%
|
3.25%
|
2.57%
|
2.67%
|
-
|
2.16%
|
2.24%
|
Announcement Date
|
1/30/20
|
2/5/21
|
3/17/22
|
2/6/23
|
1/29/24
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
10,930
KRW Average target price
15,333
KRW Spread / Average Target +40.29% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.07% | 527M | | +19.62% | 43.34B | | +20.44% | 21.96B | | +10.86% | 14.09B | | +13.07% | 13.64B | | +37.46% | 11.43B | | -8.59% | 6.86B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +8.46% | 5.22B |
Generic Pharmaceuticals
|